healthcare reform
Shifting from a Treatment Model to Personalized Medicine - The Role of the Medical Device Industry
Written by: MDCI Blogging TeamThursday, July 1st, 2010 | Industry News and Innovations, Medical Device Market | No Comments
Personalized medicine is a term that has become something of a media buzzword over the past 12 months, due in part to the increased attention paid to the field by those on both sides of the current healthcare debate. While this phrase might be only now entering the common lexicon used by news outlets reporting on the health industry, MDCI has been actively involved in personalized medicine for many years, and we consider it one of our organization’s core competencies. › Continue reading
Thoughts on InHealth’s Evidence and Reform Summit
Written by: Michael FeldsteinWednesday, November 18th, 2009 | Industry News and Innovations | No Comments
I recently attended a special health technology summit meeting on “Evidence and Reform”. The summit was presented by InHealth, an independent, non-partisan 501(c)(3) charitable foundation, founded in 2003 at the initiative of the board of directors of AdvaMed.
The summit meeting addressed topics in healthcare policy and health technology research in the light of the current US administration’s focus on health care reform. Attendees included medtech industry leaders, academic researchers, and clinical professionals. The objective was to increase understanding of how rapidly advancing healthcare technologies contribute to the enhancement of healthcare systems in the United States and around the world by improving patient outcomes, productivity, and quality of life. › Continue reading
Subscribe via Email
Search
Contributors
Categories
Archives
Recent Posts
- FDA Publishes Rule to Require PMA or PDP for Four Class III Preamendment Devices
- Industry Slow to Respond to FDA Call for Infusion Pump Assurance Case Reports and Clinical Evaluations
- FDA Update - CDRH Issues Medical Device Recommendations
- Q1 Conference in Baltimore Highlights FDA Regulatory Challenges for Combination Products
- FDA Could Tighten Focus on Human Factors Testing for Medical Devices